Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment
Arch Rheumatol
.
2019 Nov 6;35(2):300-302.
doi: 10.46497/ArchRheumatol.2020.7555.
eCollection 2020 Jun.
Authors
Veli Yazisiz
1
,
İsmail UÇar
1
,
Bengisu Aslan
1
,
Funda Erbasan
1
,
Mustafa Ender TerzioĞlu
1
Affiliation
1
Department of Internal Medicine, Division of Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
PMID:
32851383
PMCID:
PMC7406168
DOI:
10.46497/ArchRheumatol.2020.7555
No abstract available